SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes

Launched by KAROLINSKA INSTITUTET · Apr 25, 2022

Keywords

ClinConnect Summary

The SPARK trial is studying a new mobile health platform designed to help women manage gestational diabetes mellitus (GDM), a condition that can arise during pregnancy. The goal is to see if using this digital tool can improve how women control their blood sugar levels and promote healthier lifestyles, which may lead to better outcomes for both mothers and their babies. Women diagnosed with GDM in South Eastern Sweden can participate in this study. To be eligible, they must have a confirmed diagnosis of GDM, but those with pre-existing diabetes, carrying twins, or under 18 years old cannot join.

Participants in the trial will be divided into two groups. Everyone will receive standard care for managing GDM, but one group will also get access to the SPARK platform, which offers guidance on healthy eating, exercise, and blood sugar management. The study will track important health measures, including blood sugar control, diet, and physical activity, up to one year after childbirth. By joining this trial, women have the opportunity to receive extra support during their pregnancy while helping researchers learn more about effective ways to manage gestational diabetes.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • a confirmed diagnosis of GDM detected by oral glucose tolerance test in accordance with the World Health Organization guidelines
• Exclusion Criteria:
• • known pre-pregnancy diabetes
• • twin pregnancy
• • \<18 years of age
• • severe co-morbidities that would limit participation or a previously diagnosed severe psychiatric illness.